Background
We conducted a diagnostic surveillance study to identify
Plasmodium
, dengue virus, chikungunya virus, and
Orientia tsutsugamushi
infections among febrile patients who underwent triage for malaria in the outpatient department at Ispat General Hospital, Rourkela, Odisha, India.
Methods
Febrile patients were enrolled from January 2016–January 2017. Blood smears and small volumes or vacutainers of blood were collected from study participants to carry out diagnostic assays. Malaria was diagnosed using rapid diagnostic tests (RDT), microscopy, and PCR. Dengue, chikungunya, and scrub typhus infections were identified using rapid diagnostic test kits and ELISA.
Results
Nine hundred and fifty-four patients were prospectively enrolled in our study. The majority of patients were male (58.4%) and more than 15 years of age (66.4%). All 954 enrollees underwent additional testing for malaria; a subset of enrollees (293/954) that had larger volumes of plasma available was also tested for dengue, chikungunya and scrub typhus by either RDT or ELISA or both tests. Fifty-four of 954 patients (5.7%) were positive for malaria by RDT, or microscopy, or PCR. Seventy-four of 293 patients (25.3%) tested positive for dengue by either RDT or ELISA, and 17 of 293 patients (5.8%) tested positive for chikungunya-specific IgM by either ELISA or RDT. Ten of 287 patients tested (3.5%) were positive for scrub typhus by ELISA specific for scrub typhus IgM. Seventeen patients among 290 (5.9%) with results for ≥3 infections tested positive for more than one infection. Patients with scrub typhus and chikungunya had high rates of co-infection: of the 10 patients positive for scrub typhus, six were positive for dengue (
p
= 0.009), and five of 17 patients positive for chikungunya (by RDT or ELISA) were also diagnosed with malaria (
p
< 0.001).
Conclusions
Dengue, chikungunya and scrub typhus are important etiologies of non-malarial febrile illness in Rourkela, Odisha, and comorbidity should be considered. Routine febrile illness surveillance is required to accurately establish the prevalence of these infections in this region, to offer timely treatment, and to implement appropriate methods of control.
Electronic supplementary material
The online version of this article (10.1186/s12879-019-4161-6) contains supplementary material, which is available to authorized users.
Postmortem examination of a wild Asian elephant at Rajiv Gandhi National Park, India, revealed nodular lesions, granulomas with central caseation, and acid-fast bacilli in the lungs. PCR and nucleotide sequencing confirmed the presence of Mycobacterium tuberculosis. This study indicates that wild elephants can harbor M. tuberculosis that can become fatal.
We report the protective antigen gene based molecular epidemiology of a massive anthrax outbreak in sheep that killed over 100 sheep. The outbreak was unique since the use of higher antibiotics immediately after the live anthrax vaccine had facilitated wide spread of the disease and unscientific disposal of carcasses had precipitated the disease magnitude. B. anthracis was isolated from ear blood samples collected from dead sheep. The isolates were non-motile, non-hemolytic and were pathogenic to mice. Gene coding for the toxic factor 'protective antigen' was targeted for PCR amplification as per WHO and OIE protocols. Sequencing of nucleotides on the conserved pag gene showed that the B. anthracis isolated during this study shared a sequence identity of more than 99.9% with B. anthracis isolates from different species, including human beings. The phylogeny demonstrated the genetic stability of the immunologically protective pag gene across species.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.